What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;

Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016 Edgar Denova-Gutiérrez; Laura Lara-Castor; Cesar Hernández-Alcaraz; Mauricio Hernández-Ávila; Carlos Aguilar-Salinas; David Kershenobich; Simón Barquera;

Alpha-1 antitrypsin Pi*MZ variant increases the risk of liver disease progression in MASLD and MASH Bradley Jermy; Jack Brownrigg; Pavel Strnad; Rohit Loomba;